Lexicon Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · The Woodlands, TX
LXRX chart
What traders are saying about $LXRX
Latest postsLexicon Pharmaceuticals, Inc. news
- Lexicon Pharmaceuticals, Inc. (LXRX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Citigroup maintains Lexicon Pharmaceuticals at Buy, raises price target to $3.40 from $3.10
TradingView ·
- Lexicon Pharmaceuticals (LXRX) CEO Michael Exton Buys 30,064 Sha
GuruFocus ·
- Lexicon Pharmaceuticals CEO Michael Exton buys $49,999 in shares By Investing.com
Investing.com South Africa ·
- Form 4 Lexicon Pharmaceuticals Inc: Michael Exton (Director, CEO) For: 6 November
Investing.com Nigeria ·
- New Data at 2026 American Heart Association Scientific Sessions Highlight Cardiovascular Effects of Sotagliflozin on Thrombus Formation and in Hypertrophic Cardiomyopathy
Yahoo Finance ·
- A drug cut the workload of living heart tissue from people with thickened heart muscle.
Stock Titan ·
- Lexicon Pharmaceuticals (LXRX) CEO Exton bought 30,064 shares for $50K at $1.66
Quantisnow ·
- After buying 30,064 shares, Lexicon Pharmaceuticals (LXRX) CEO directly holds 328,496 shares.
Stock Titan ·
- Cantor Fitzgerald Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $8
Moomoo ·
- What Lexicon Pharmaceuticals (LXRX) Said on Its Q3 Earnings Call
marketbeat.com ·
- Lexicon Pharmaceuticals Inc (LXRX) (Q3 2026) Earnings Call Highlights: Sonata HCM Data and ...
Yahoo Finance ·
Lexicon Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $6.0M | $1.1M | $0 |
| Net income | -$50.3M | -$200.4M | -$177.1M | -$101.9M |
| Diluted EPS | $-0.14 | $-0.63 | $-0.80 | $-0.62 |
| Total assets (year end) | $185.0M | $298.4M | $229.4M | $194.3M |
| Cash and equivalents (year end) | $34.3M | $66.7M | $22.5M | $46.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Lexicon Pharmaceuticals, Inc.
- Ticker
- LXRX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- The Woodlands, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1062822
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
Frequently asked questions
What exchange is Lexicon Pharmaceuticals, Inc. listed on?
Lexicon Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol LXRX.
What industry is Lexicon Pharmaceuticals, Inc. in?
Lexicon Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Lexicon Pharmaceuticals, Inc. headquartered?
Lexicon Pharmaceuticals, Inc.'s business address on file with the SEC is in The Woodlands, TX.
When does Lexicon Pharmaceuticals, Inc.'s fiscal year end?
Lexicon Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Lexicon Pharmaceuticals, Inc. report?
Lexicon Pharmaceuticals, Inc. reported $6.0M in revenue for calendar year 2024, according to its SEC filings.